Prescription drug · ANDA
Ethosuximide NDC 68999-064
Ethosuximide 250 mg/5mL · Solution · Oral · Chartwell Governmental & Specialty RX, LLC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68999-064-24 | 68999006424 | 2 TRAY in 1 BOX (68999-064-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (68999-064-05)Marketed from Jun 9, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ethosuximide
- Generic name (nonproprietary)
- ethosuximide
- Active ingredients
- Ethosuximide — 250 mg/5mL
- Dosage form
- Solution
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040506
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
- Identifiers
- Product ID 68999-064_53fe494e-ed69-2aad-e063-6294a90a70e4SPL ID 53fe494e-ed69-2aad-e063-6294a90a70e4SPL set ID a825265d-ace9-4463-a16d-f6d5e1e31188RxCUI 251322UNII 5SEH9X1D1D
- Pharmacologic class
- Anti-epileptic Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468999006424followed by a unit qualifier and the quantityPackage 68999-0064-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Ethosuximide is indicated for the control of absence (petit mal) epilepsy.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 040506
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Ethosuximide | Ethosuximide 250 mg/5mL | SolutionOral | Chartwell RX, LLC | 62135-064 |